Spots Global Cancer Trial Database for monomethylauristatin f
Every month we try and update this database with for monomethylauristatin f cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Safety Study of SGN-CD19A for Leukemia and Lymphoma | NCT01786096 | Burkitt Lymphom... Precursor B-cel... | SGN-CD19A | 1 Year - | Seagen Inc. | |
| A Safety Study of SGN-CD19A for B-Cell Lymphoma | NCT01786135 | Burkitt Lymphom... Lymphoma, Folli... Lymphoma, Large... Lymphoma, Mantl... Precursor B-cel... | SGN-CD19A | 12 Years - | Seagen Inc. | |
| A Phase 1b Study of SGN-75 in Combination With Everolimus in Patients With Renal Cell Carcinoma | NCT01677390 | Renal Cell Carc... | SGN-75 everolimus | 18 Years - | Seagen Inc. | |
| A Safety Study of SGN-CD19A for B-Cell Lymphoma | NCT01786135 | Burkitt Lymphom... Lymphoma, Folli... Lymphoma, Large... Lymphoma, Mantl... Precursor B-cel... | SGN-CD19A | 12 Years - | Seagen Inc. | |
| A Safety Study of SGN-CD19A for Leukemia and Lymphoma | NCT01786096 | Burkitt Lymphom... Precursor B-cel... | SGN-CD19A | 1 Year - | Seagen Inc. | |
| A Phase 1b Study of SGN-75 in Combination With Everolimus in Patients With Renal Cell Carcinoma | NCT01677390 | Renal Cell Carc... | SGN-75 everolimus | 18 Years - | Seagen Inc. | |
| A Phase 1 Dose-escalation Trial of SGN-75 in CD70-positive Non-Hodgkin Lymphoma or Renal Cell Carcinoma | NCT01015911 | Carcinoma, Rena... Lymphoma, Non-H... | SGN-75 | 18 Years - | Seagen Inc. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
